ZA929709B - Method and composition for ameliorating tissue damage due to ischemia and reperfusion - Google Patents

Method and composition for ameliorating tissue damage due to ischemia and reperfusion

Info

Publication number
ZA929709B
ZA929709B ZA9229709A ZA9229709A ZA929709B ZA 929709 B ZA929709 B ZA 929709B ZA 9229709 A ZA9229709 A ZA 9229709A ZA 9229709 A ZA9229709 A ZA 9229709A ZA 929709 B ZA929709 B ZA 929709B
Authority
ZA
South Africa
Prior art keywords
reperfusion
ischemia
composition
tissue damage
damage due
Prior art date
Application number
ZA9229709A
Other languages
English (en)
Inventor
Gary T Elliott
Original Assignee
Ribi Immunochem Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribi Immunochem Research Inc filed Critical Ribi Immunochem Research Inc
Publication of ZA929709B publication Critical patent/ZA929709B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
ZA9229709A 1991-12-31 1992-01-01 Method and composition for ameliorating tissue damage due to ischemia and reperfusion ZA929709B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/815,250 US5286718A (en) 1991-12-31 1991-12-31 Method and composition for ameliorating tissue damage due to ischemia and reperfusion

Publications (1)

Publication Number Publication Date
ZA929709B true ZA929709B (en) 1993-06-14

Family

ID=25217292

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9229709A ZA929709B (en) 1991-12-31 1992-01-01 Method and composition for ameliorating tissue damage due to ischemia and reperfusion

Country Status (10)

Country Link
US (1) US5286718A (ja)
EP (2) EP1068869A3 (ja)
JP (1) JPH07503709A (ja)
KR (1) KR0156597B1 (ja)
AU (1) AU657037B2 (ja)
DE (1) DE69232033T2 (ja)
ES (1) ES2160592T3 (ja)
NZ (1) NZ245448A (ja)
WO (1) WO1993012778A1 (ja)
ZA (1) ZA929709B (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747296A (en) * 1992-05-11 1998-05-05 Corvas International, Inc. Method of detecting neutophil inhibitory factor mimics
WO1996038483A1 (en) * 1995-05-31 1996-12-05 The University Of Alabama At Birmingham Research Foundation Monoclonal and polyclonal antibodies against recombinant human xanthine oxidase, method for their use and a kit containing same
JP3604467B2 (ja) * 1995-09-27 2004-12-22 株式会社東芝 心筋のねじれ補正方法
US6348567B1 (en) * 1995-12-06 2002-02-19 Cv Molecular Therapeutics Inc. Peptides and their use to ameliorate cell death
US5762943A (en) * 1996-05-14 1998-06-09 Ribi Immunochem Research, Inc. Methods of treating type I hypersensitivity using monophosphoryl lipid A
WO1999020284A1 (en) * 1997-10-23 1999-04-29 Trustees Of The University Of Pennsylvania Methods for reducing ischemic injury of the heart via the sequential administration of monophosphoryl lipid a and adenosine receptor agents
US6013640A (en) * 1998-08-21 2000-01-11 Ribi Immunochem Research, Inc. Phosphoglycolipid and methods for its use
US6699846B2 (en) * 2000-03-17 2004-03-02 Corixa Corporation Mono- and disaccharides for the treatment of nitric oxide related disorders
US20030139356A1 (en) * 2001-05-18 2003-07-24 Persing David H. Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
US20030105032A1 (en) * 2000-05-19 2003-06-05 Persing David H. Phophylactic and therapeutic treatment of infectious and other diseases with mono-and disaccharide-based compounds
US20080039408A1 (en) * 2004-12-06 2008-02-14 Ronald Freudenberger Use of Oxypurinol as an Inhibitor of Anti-Neoplastic Agent-Induced Cardiotoxicity
DK2068918T4 (da) 2006-09-26 2024-09-02 Access To Advanced Health Inst Vaccinesammensætning omfattende syntetisk adjuvant
US20090181078A1 (en) 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
EP3124491B1 (en) 2009-06-05 2019-10-30 Infectious Disease Research Institute Synthetic glucopyranosyl lipid adjuvants and vaccine compositions as well as pharmaceutical compositions containing them
JP6054942B2 (ja) 2011-04-08 2016-12-27 イミューン デザイン コーポレイション 免疫原性組成物、ならびに体液性および細胞性免疫応答を誘発するための該組成物の使用方法
WO2012170633A1 (en) 2011-06-09 2012-12-13 Lifeline Scientific, Inc. Data record for organ transport and/or storage, comprising biomarker and events information
CN107540730B (zh) 2012-05-16 2021-07-16 免疫设计公司 用于hsv-2的疫苗
US20140278468A1 (en) 2013-03-15 2014-09-18 I.D. Therapeutics Llc Apparatus and method for optimizing treatment using medication compliance patterns and glucose sensor
US10420337B2 (en) 2013-03-15 2019-09-24 Lifeline Scientific, Inc. Transporter with a glucose sensor for determining viability of an organ or tissue
BR112015025709A2 (pt) 2013-04-18 2017-07-18 Immune Design Corp monoterapia com gla para uso em tratamento de câncer
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
ES2927427T3 (es) * 2016-01-15 2022-11-04 Childrens Medical Ct Corp Uso terapéutico de mitocondrias y agentes mitocondriales combinados

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4436727A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4976959A (en) * 1986-05-12 1990-12-11 Burroughs Wellcome Co. T-PA and SOD in limiting tissue damage
US4985241A (en) * 1986-11-21 1991-01-15 Cetus Corporation Therapeutic combination of free-radical scavenger and tumor necrosis factor
US4912094B1 (en) * 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation

Also Published As

Publication number Publication date
NZ245448A (en) 1997-08-22
EP0660719B1 (en) 2001-08-29
US5286718A (en) 1994-02-15
EP1068869A2 (en) 2001-01-17
EP1068869A3 (en) 2002-10-09
DE69232033D1 (de) 2001-10-04
KR0156597B1 (ko) 1998-11-16
ES2160592T3 (es) 2001-11-16
KR940703658A (ko) 1994-12-12
EP0660719A1 (en) 1995-07-05
DE69232033T2 (de) 2002-06-06
JPH07503709A (ja) 1995-04-20
EP0660719A4 (en) 1995-03-02
AU657037B2 (en) 1995-02-23
AU3272293A (en) 1993-07-28
WO1993012778A1 (en) 1993-07-08

Similar Documents

Publication Publication Date Title
ZA929709B (en) Method and composition for ameliorating tissue damage due to ischemia and reperfusion
GB2220319B (en) Improvements in or relating to image stabilisation
GB8814843D0 (en) Improvements in & relating to gaskets
GB8825197D0 (en) Improvements in & relating to gaskets
GB2203806B (en) Improvements in and relating to cylinder head gaskets
GB8811883D0 (en) Improvements in & relating to overvoltage protectors
GB2278819B (en) Improvements in or relating to carriers
ZA955865B (en) The use of (s)-adenosyl-l-methionine (same) and its physiologically tolerated salts for treating reperfusion damage caused by temporary focal ischemia
EP0344708A3 (en) Composition for external application to skin
GB9323941D0 (en) Improvements in or relating to clamping devices
GB9107599D0 (en) Improvements in and relating to sealing compositions
EP0446124A3 (en) Use of antiprogestomimetics to synchronise parturition in livestock
GB9321651D0 (en) Improvements in and relating to rheology
GB8815710D0 (en) Improvements in & relating to curtainsided trailers
GB9102357D0 (en) Improvements in and relating to seals
GB9105092D0 (en) Improvements in and relating to floating structures
GB2252355B (en) Improvements in or relating to clamp assemblies
GB2252354B (en) Improvements in or relating to clamp assemblies
GB8819746D0 (en) Improvements in/relating to nozzles
IL105005A0 (en) Compositions for aiding in the regeneration of tissue with a prolonged immunomodulating effect
AU590506B3 (en) Improvements in and relating to bow ties
GB9308176D0 (en) Improvements relating to towing arrangements
GB9208192D0 (en) Improvements in or relating to divan beds
GB9121903D0 (en) Improvements in or relating to hats
RO93513B1 (ro) Procedeu de obtinere a unui vaccin viu atenuat destinat imunizarii ovinelor contra parainfluentei tip 3